Cesca Therapeutics Inc. is selling 609,636 common shares at $2.27 apiece and unregistered warrants to buy up to 304,818 common shares in a registered direct offering with certain institutional investors.
Each warrant is exercisable for $2.68 apiece six months after the issuance date and will expire within a 5.5-year period.
Gross proceeds from the offering are expected to amount to about $1.4 million. The offering is expected to close March 28, subject to customary closing conditions.
H.C. Wainwright & Co. is acting as the exclusive placement agent in the offering.